TY - JOUR
T1 - The global impact of the DRACMA guidelines cow's milk allergy clinical practice
AU - Fiocchi, Alessandro
AU - Schunemann, Holger
AU - Ansotegui, Ignacio
AU - Assa'Ad, Amal
AU - Bahna, Sami
AU - Canani, Roberto Berni
AU - Bozzola, Martin
AU - Dahdah, Lamia
AU - Dupont, Christophe
AU - Ebisawa, Motohiro
AU - Galli, Elena
AU - Li, Haiqi
AU - Kamenwa, Rose
AU - Lack, Gideon
AU - Martelli, Alberto
AU - Pawankar, Ruby
AU - Said, Maria
AU - Sánchez-Borges, Mario
AU - Sampson, Hugh
AU - Shamir, Raanan
AU - Spergel, Jonathan
AU - Terracciano, Luigi
AU - Vandenplas, Yvan
AU - Venter, Carina
AU - Waserman, Susan
AU - Wong, Gary
AU - Brozek, Jan
N1 - Publisher Copyright:
Copyright © 2018, The Author(s).
PY - 2018
Y1 - 2018
N2 - Background The 2010 Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines are the only Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines for cow's milk allergy (CMA). They indicate oral food challenge (OFC) as the reference test for diagnosis, and suggest the choice of specific alternative formula in different clinical conditions. Their recommendations are flexible, both in diagnosis and in treatment. Objectives & methods Using the Scopus citation records, we evaluated the influence of the DRACMA guidelines on milk allergy literature. We also reviewed their impact on successive food allergy and CMA guidelines at national and international level. We describe some economic consequences of their application. Results DRACMA are the most cited CMA guidelines, and the second cited guidelines on food allergy. Many subsequent guidelines took stock of DRACMA's metanalyses adapting recommendations to the local context. Some of these chose not to consider OFC as an absolute requirement for the diagnosis of CMA. Studies on their implementation show that in this case, the treatment costs may increase and there is a risk of overdiagnosis. Interestingly, we observed a reduction in the cost of alternative formulas following the publication of the DRACMA guidelines. Conclusions DRACMA reconciled international differences in the diagnosis and management of CMA. They promoted a cultural debate, improved clinician's knowledge of CMA, improved the quality of diagnosis and care, reduced inappropriate practices, fostered the efficient use of resources, empowered patients, and influenced some public policies. The accruing evidence on diagnosis and treatment of CMA necessitates their update in the near future.
AB - Background The 2010 Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) guidelines are the only Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines for cow's milk allergy (CMA). They indicate oral food challenge (OFC) as the reference test for diagnosis, and suggest the choice of specific alternative formula in different clinical conditions. Their recommendations are flexible, both in diagnosis and in treatment. Objectives & methods Using the Scopus citation records, we evaluated the influence of the DRACMA guidelines on milk allergy literature. We also reviewed their impact on successive food allergy and CMA guidelines at national and international level. We describe some economic consequences of their application. Results DRACMA are the most cited CMA guidelines, and the second cited guidelines on food allergy. Many subsequent guidelines took stock of DRACMA's metanalyses adapting recommendations to the local context. Some of these chose not to consider OFC as an absolute requirement for the diagnosis of CMA. Studies on their implementation show that in this case, the treatment costs may increase and there is a risk of overdiagnosis. Interestingly, we observed a reduction in the cost of alternative formulas following the publication of the DRACMA guidelines. Conclusions DRACMA reconciled international differences in the diagnosis and management of CMA. They promoted a cultural debate, improved clinician's knowledge of CMA, improved the quality of diagnosis and care, reduced inappropriate practices, fostered the efficient use of resources, empowered patients, and influenced some public policies. The accruing evidence on diagnosis and treatment of CMA necessitates their update in the near future.
UR - http://www.scopus.com/inward/record.url?scp=85042615588&partnerID=8YFLogxK
U2 - 10.1186/s40413-017-0179-7
DO - 10.1186/s40413-017-0179-7
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
AN - SCOPUS:85042615588
SN - 1939-4551
VL - 11
JO - World Allergy Organization Journal
JF - World Allergy Organization Journal
IS - 1
M1 - 2
ER -